| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |